Clinical trial
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
NCT00660218 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
- Lead sponsor
- State University of New York - Upstate Medical University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- April 30, 2017
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.